Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bristol-Myers Squibb Co BMY

Healthcare
Bristol-Myers Squibb Company is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule... see more

Recent & Breaking News (NYSE:BMY)

Bristol-Myers Squibb to Announce Results for Second Quarter 2016 on July 28

Business Wire June 9, 2016

Holding(s) in Company

UK Regulatory news services, from the LSE June 9, 2016

Director/PDMR Shareholding

UK Regulatory news services, from the LSE June 9, 2016

Net Asset Value(s)

UK Regulatory news services, from the LSE June 9, 2016

Bristol-Myers Squibb to Present New Data Demonstrating Continued Research Expansion and Immuno-Oncology Advancements Across Multiple Blood Cancers at the 21st Congress of the European Hematology Association

Business Wire June 9, 2016

Bristol-Myers Squibb Reveals Fresh Rheumatoid Arthritis Research And Real-World Data At European Congress Of Rheumatology

Benzinga.com  June 8, 2016

Bristol-Myers Squibb Announces New Rheumatoid Arthritis Research and Real-World Data at the Annual European Congress of Rheumatology (EULAR 2016)

Business Wire June 8, 2016

Bristol-Myers Squibb Announces Dividend

Business Wire June 7, 2016

Bristol-Myers And MD Anderson Cancer Center Makes Fresh Research Alliance In Immuno-Oncology Focused On Lung-Cancer

Benzinga.com  June 7, 2016

Bristol-Myers Squibb and MD Anderson Announce New Research Collaboration in Immuno-Oncology Focused on Lung Cancer

Business Wire June 7, 2016

4 Key Takeaways From ASCO

Benzinga.com  June 6, 2016

Mid-Afternoon Market Update: Helios and Matheson Analytics Jumps Amid News Of Merger With Zone Technologies; ProNAi Therapeutics Shares Drop

Benzinga.com  June 6, 2016

Long-Term Data from Two Trials Evaluating the Opdivo® (nivolumab) and Yervoy® (ipilimumab) Regimen in Advanced Melanoma Continues to Validate Bristol-Myers Squibb’s Immuno-Oncology Combination Approach

Business Wire June 6, 2016

Long-Term Survival and Improvement in Quality of Life Observed with Opdivo® (nivolumab) in Advanced Renal Cell Carcinoma Patients Based on New Data Presented at the 2016 ASCO Annual Meeting

Business Wire June 5, 2016

First Presentation of Phase 2 CheckMate -142 Study Evaluating Opdivo® (nivolumab) Alone or in Combination with Yervoy® (ipilimumab) Demonstrates Encouraging Clinical Activity in MSI-High Metastatic Colorectal Cancer

Business Wire June 5, 2016

Promising Response Rates with Opdivo® (nivolumab) Observed in Advanced Form of Bladder Cancer from Phase 1/2 Study CheckMate -032

Business Wire June 5, 2016

Bristol-Myers Squibb to Take Part in Goldman Sachs 37th Annual Global Health Care Conference

Business Wire May 31, 2016

Employee Benefit Trust purchase of shares

UK Regulatory news services, from the LSE May 27, 2016

Employee Benefit Trust purchase of shares

UK Regulatory news services, from the LSE May 24, 2016

Form 8.5 (EPT/RI) - Rexam Plc

UK Regulatory news services, from the LSE May 23, 2016